Medisse BV - Product Pipeline Analysis
Publisher Name » GlobalData
Published Date » 2012-05-17
No. Of Pages » 22
Medisse BV - Product Pipeline Analysis
Summary
Medisse BV (Medisse) is a biotechnology company that carries out the development of resorbable medical implants for soft tissue applications. It offers products such as FlexiSurge Mesh bio-resorbable film and FlexiSurge adhesion barrier, which are based on a material formed from PTMC (Poly 1, 3- trimethylene carbonate) networks. The companys products find application in gynecology, general surgery, dermatology, drug delivery and ophthalmology. Its products comprises staple-line reinforcement products and periodontal sheets. The company has its own proprietary technology for making PTMC networks and its laboratory is located in the premises of the University of Twente.
This report is a source for data, analysis and actionable intelligence on the Medisse BV portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Summary
Medisse BV (Medisse) is a biotechnology company that carries out the development of resorbable medical implants for soft tissue applications. It offers products such as FlexiSurge Mesh bio-resorbable film and FlexiSurge adhesion barrier, which are based on a material formed from PTMC (Poly 1, 3- trimethylene carbonate) networks. The companys products find application in gynecology, general surgery, dermatology, drug delivery and ophthalmology. Its products comprises staple-line reinforcement products and periodontal sheets. The company has its own proprietary technology for making PTMC networks and its laboratory is located in the premises of the University of Twente.
This report is a source for data, analysis and actionable intelligence on the Medisse BV portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Medisse BV - Major Products and Services 5
Medisse BV Pipeline Products by Equipment Type 6
Medisse BV Pipeline Products by Development Stage 8
Medisse BV Pipeline Products by Therapy Area 10
Medisse BV Pipeline Products by Milestone Summary 12
FlexiSurge Adhesive Barrier 14
FlexiSurge Adhesive Barrier Product Status 14
FlexiSurge Adhesive Barrier Product Description 14
FlexiSurge Adhesive Barrier Product Milestone 14
FlexiSurge Mesh 16
FlexiSurge Mesh Product Status 16
FlexiSurge Mesh Product Description 16
Product Institution Details 16
FlexiSurge Scleral Buckle 17
FlexiSurge Scleral Buckle Product Status 17
FlexiSurge Scleral Buckle Product Description 17
Medisse BV - Key Competitors 18
Medisse BV - Key Employees 19
Medisse BV - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Medisse BV, Recent Developments 21
Jul 20, 2011: Medisse Moves To Its New Premises In Leusden 21
Mar 07, 2011: Medisse Appoints Alexander Vos To Supervisory Board 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
Medisse BV, Key Facts 1
Medisse BV Key Pipeline Products by Equipment Type 1
Medisse BV Key Pipeline Products by Therapy Area 1
Medisse BV Key Pipeline Products by Development Stage 1
Medisse BV, Key Facts 4
Medisse BV, Major Products and Services 5
Medisse BV Number of Pipeline Products by Equipment Type 6
Medisse BV Pipeline Products by Equipment Type 7
Medisse BV Number of Pipeline Products by Development Stage 8
Medisse BV Pipeline Products by Development Stage 9
Medisse BV Number of Pipeline Products by Therapy Area 10
Medisse BV Pipeline Products by Therapy Area 11
Medisse BV Number of Pipeline Products By Milestone Summary 12
Medisse BV Pipeline Products by Milestone Summary 13
FlexiSurge Adhesive Barrier - Product Status 14
FlexiSurge Adhesive Barrier - Product Description 14
FlexiSurge Adhesive Barrier - Product Milestone 14
FlexiSurge Mesh - Product Status 16
FlexiSurge Mesh - Product Description 16
FlexiSurge Scleral Buckle - Product Status 17
FlexiSurge Scleral Buckle - Product Description 17
Medisse BV, Key Employees 19
Medisse BV Pipeline Products by Equipment Type 6
Medisse BV Pipeline Products by Development Stage 8
Medisse BV Pipeline Products by Therapy Area 10
Medisse BV Pipeline Products by Milestone Summary 12
Table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Medisse BV - Major Products and Services 5
Medisse BV Pipeline Products by Equipment Type 6
Medisse BV Pipeline Products by Development Stage 8
Medisse BV Pipeline Products by Therapy Area 10
Medisse BV Pipeline Products by Milestone Summary 12
FlexiSurge Adhesive Barrier 14
FlexiSurge Adhesive Barrier Product Status 14
FlexiSurge Adhesive Barrier Product Description 14
FlexiSurge Adhesive Barrier Product Milestone 14
FlexiSurge Mesh 16
FlexiSurge Mesh Product Status 16
FlexiSurge Mesh Product Description 16
Product Institution Details 16
FlexiSurge Scleral Buckle 17
FlexiSurge Scleral Buckle Product Status 17
FlexiSurge Scleral Buckle Product Description 17
Medisse BV - Key Competitors 18
Medisse BV - Key Employees 19
Medisse BV - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Medisse BV, Recent Developments 21
Jul 20, 2011: Medisse Moves To Its New Premises In Leusden 21
Mar 07, 2011: Medisse Appoints Alexander Vos To Supervisory Board 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
List of TablesMedisse BV, Key Facts 1
Medisse BV Key Pipeline Products by Equipment Type 1
Medisse BV Key Pipeline Products by Therapy Area 1
Medisse BV Key Pipeline Products by Development Stage 1
Medisse BV, Key Facts 4
Medisse BV, Major Products and Services 5
Medisse BV Number of Pipeline Products by Equipment Type 6
Medisse BV Pipeline Products by Equipment Type 7
Medisse BV Number of Pipeline Products by Development Stage 8
Medisse BV Pipeline Products by Development Stage 9
Medisse BV Number of Pipeline Products by Therapy Area 10
Medisse BV Pipeline Products by Therapy Area 11
Medisse BV Number of Pipeline Products By Milestone Summary 12
Medisse BV Pipeline Products by Milestone Summary 13
FlexiSurge Adhesive Barrier - Product Status 14
FlexiSurge Adhesive Barrier - Product Description 14
FlexiSurge Adhesive Barrier - Product Milestone 14
FlexiSurge Mesh - Product Status 16
FlexiSurge Mesh - Product Description 16
FlexiSurge Scleral Buckle - Product Status 17
FlexiSurge Scleral Buckle - Product Description 17
Medisse BV, Key Employees 19
List of Figures
List of FiguresMedisse BV Pipeline Products by Equipment Type 6
Medisse BV Pipeline Products by Development Stage 8
Medisse BV Pipeline Products by Therapy Area 10
Medisse BV Pipeline Products by Milestone Summary 12
Upcoming Reports:
|
Ribbed Smoked Sheet Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
By - Transparency Market Research
Ribbed smoke sheet is a natural rubber in the form of a sheet which is used in various industries owing to its properties like tear strength and cleanliness. The main reason the rubber sheet is smoked is to improve its tensile strength.
The ribbed smoke sheet market suffered a setback during 2008 – 2009 when the global economy was under pressure, but since then the global ribbed smoke market is growing at a healthy pace. The major factors which are contributing to the continuous growth of the market include the growth of the global automotives market which...
|
|
Autologous Cell Therapy Market - Global Forecast, Market Share, Size, Growth and Industry Analysis, 2011-2018
By - Transparency Market Research
Autologous cell therapy is a therapeutic procedure which uses the cells of an individual, which are well-bred and nurtured outside the body and then reintroduced at the site of the disease of the individual. Autologous cell therapy is a new breakthrough in the field of medical history. Autologous cell therapy (ACT) is one of the most rapidly evolving fields due to the revolution in the bioengineering sector since the last few decades.
Previously diseases like Alzheimer’s, Parkinson's were thought to be incurable; however the invention of Autologous cell therapy...
|
|
Heart Valve Devices Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Heart valves are medical devices used to treat heart diseases. They are used to replace diseased heart valves in patients. Heart valve devices are mostly used in the elderly demographic, because this age group suffers the most from valve disease. Heart valves are diversified into three categories - mechanical, tissue and biological types.
The global heart valve devices market will grow strongly as the market shows a strong growth rate due to the arrival of transcatheter aortic valve replacement (TAVR) devices, the introduction of new minimally invasive devices and the...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- Global and China Piano Industry Report, 2012-2013
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|

